Form 4 for EOG EOG Resources
Accepted 2026-03-23 00:00:00 ET · period of report 2026-03-19 · accession 0000821189-26-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-23 | 2026-03-19 | EOG | Janssen Ann D. | EVP, CFO | D - Sale to Iss | $140.06 | -2,504 | 107.1K | -2% | -$350.7K |
| D | 2026-03-23 | 2026-03-19 | EOG | Janssen Ann D. | EVP, CFO | S - Sale+OE | $140.04 | -4,161 | 100.2K | -4% | -$582.7K |
| D | 2026-03-23 | 2026-03-19 | EOG | Janssen Ann D. | EVP, CFO | F - Tax | $140.06 | -2,700 | 104.4K | -3% | -$378.2K |
| D | 2026-03-23 | 2026-03-19 | EOG | Janssen Ann D. | EVP, CFO | M - OptEx | $37.44 | +9,365 | 109.6K | +9% | +$350.6K |
| D | 2026-03-23 | 2026-03-19 | EOG | Janssen Ann D. | EVP, CFO | M - OptEx | $0.00 | -9,365 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-19 | D | D | 2,504 | $140.06 | 107,107.38 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-19 | S | D | 4,161 | $140.04 | 100,246.38 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-19 | F | D | 2,700 | $140.06 | 104,407.38 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-19 | M | A | 9,365 | $37.44 | 109,611.38 | D | — | — | (F1) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. |
| 5 | Derivative | Stock Appreciation Rights | 2026-03-19 | M | D | 9,365 | $0.00 | 0 | D | $37.44 · 2021-09-28 to 2027-09-28 | 9,365 Common Stock | (F1) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. |